The Cytochemistry and Morphology Core facilIty comprises three units: a Light Microscopy Unit, an Electron Microscopy Unit, and an image Analysis Unit. This Core Facility is designed to provide accessible, state-of-the art microscopy for funded investigators. A range of services and techniques are provided including routine light photomicroscopy utilizing inverted microscopes or a Zeiss Photoscope III with phase contrast, differential interference contrast, epifluorescence, or interference reflection optics, high resolution immunocytochemistry of 5, 0.5, and 0.1 micromoles frozen sections, either double or single labeled, conventional electron microscopy of plastic sections, In situ hybridization, including labeling of sections with antibodies against protein moieties, scanning confocal microscopy, and image analysis of cells, tissue sections, or photographic negatives using a Zeiss IBAS image analyzer. Drs. Susette Mueller and Wen-Tien Chen are co-directors, and together with the microscopist, Dr. Maozheng Dai, have provided state-of-the-art microscopy instrumentation and expert assistance for studies in tumor cell biology. The instrumentation and personnel have been centralized over the last two years in the Preclinical Science Building. The use of the Core facility has expanded, with the light and image analysis units becoming more heavily utilized. An additional 25% time/effort of the image analysis technician is requested to support an increasingly sophisticated utilization of the Image Analysis Unit. The proposed support for the Image Analysis Technician, Mr. Zitzmann, will allow an increase in powerful image analysis applications tailored for specific research needs. Members from seven programs of the CCSG application, and from nine departments have utilized the Cytochemistry and Morphology Core in the last two years, including work from 23 peer-reviewed funded projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-06
Application #
3731003
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lipkus, Isaac M; Mays, Darren (2018) Comparing harm beliefs and risk perceptions among young adult waterpipe tobacco smokers and nonsmokers: Implications for cessation and prevention. Addict Behav Rep 7:103-110
Tassi, Elena; Garman, Khalid A; Schmidt, Marcel O et al. (2018) Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism. Sci Rep 8:15973
Rebbeck, Timothy R (see original citation for additional authors) (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593-620
Speidell, Andrew P; Demby, Tamar; Lee, Yichien et al. (2018) Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotox Res :
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558

Showing the most recent 10 out of 1120 publications